Bellicum Pharma (BLCM) Reports Q3 Loss Per Share of $0.51

Bellicum Pharma (NASDAQ: BLCM) reported Q3 EPS of ($0.51), versus $2.08 reported last year.

For earnings history and earnings-related data on Bellicum Pharma (BLCM) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BMO starts chip stocks coverage: Here are its preferred picks
• Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue